Business
Press Release Jun 16 2023
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market". View Attachment
View stock analysis, news, and events for Natco Pharma Limited